Author Correction: TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis in Behçet’s disease

MLA

Menghao Zhang, et al. “Author Correction: TNF Inhibitors Target a Mevalonate Metabolite/TRPM2/Calcium Signaling Axis in Neutrophils to Dampen Vasculitis in Behçet’s Disease.” Nature Communications, vol. 16, no. 1, Jan. 2025, p. 1. EBSCOhost, https://doi.org/10.1038/s41467-024-55702-z.

APA

Menghao Zhang, Na Kang, Xin Yu, Xiaoyang Zhang, Qinghui Duan, Xianqiang Ma, Qiancheng Zhao, Zhimian Wang, Xiao’ou Wang, Yeling Liu, Yuxiao Zhang, Can Zhu, Ruiyu Gao, Xin Min, Cuifeng Li, Jin Jin, Qian Cao, Rongbei Liu, Xiaoyin Bai, … Wenjie Zheng. (2025). Author Correction: TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis in Behçet’s disease. Nature Communications, 16(1), 1. https://doi.org/10.1038/s41467-024-55702-z

Chicago

Menghao Zhang, Na Kang, Xin Yu, Xiaoyang Zhang, Qinghui Duan, Xianqiang Ma, Qiancheng Zhao, et al. 2025. “Author Correction: TNF Inhibitors Target a Mevalonate Metabolite/TRPM2/Calcium Signaling Axis in Neutrophils to Dampen Vasculitis in Behçet’s Disease.” Nature Communications 16 (1): 1. doi:10.1038/s41467-024-55702-z.